Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    TopAbstracts in Hypertension 07/02/2008 - (DGNews)
    Silent Cerebral Infarction Reported in 10% of Healthy People - (DGNews)
    TopAbstracts in Hypertension 06/25/2008 - (DGNews)
    Normal Range of Albumin Too Low to Predict Hypertension - (DGNews)
    Home Hypertension Monitoring Plus Web-Based Pharmacy Care Helps Improve Blood Pressure Control - (DGNews)

    News archive

     Recent webcasts/CME - Hypertension
    • Improving Outcomes in Hypertension and Congestive Heart Failure: Focus on New Generation ß-Blockers
    • Tackling a Silent Threat: Implications and Management of Peripheral Artery Disease
    • Peripheral Artery Disease: A Highly Prevalent Disease Remains Underdiagnosed and Undertreated
    • Pharmacotherapeutic Treatments for Hypertension Complicated with Proteinuria
      Hypertension in the Elderly

      Webcasts/CME archive

       Recent cases - Hypertension
        Dilation of Renal Artery Stenosis after Administration of Losartan
        Angioedema of the Tongue
        Primary Aldosteronism Caused by a Unilateral Adrenal Adenoma Accompanied by Autonomous Cortisol Secretion
        A Case of Hyperreninemic Hypertension with Bilateral Positive Captopril Renography but without Renovascular Stenosis
        Unusual Sequel of Successful Laparoscopic Unilateral Adrenalectomy in a Hypertensive Adolescent

        Cases archive
          




        my personal edition > hypertension > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Eplerenone Better Tolerated and as Effective in Reducing Systolic BP Than Amlodipine

        A DGReview of :"Symptoms and the Distress They Cause: Comparison of an Aldosterone Antagonist and a Calcium Channel Blocking Agent in Patients With Systolic Hypertension"
        Archives of Internal Medicine

        08/07/2003
        By Emma Hitt, PhD


        Compared to the calcium-channel blocker (CCB) amlodipine, the aldosterone antagonist eplerenone appears to be better tolerated and comparable in reducing systolic blood pressure, according to the findings of a new randomised trial.

        Aldosterone is known to contribute to the pathology induced by activation of the renin-angiotensin-aldosterone system. However, spironolactone, until recently the only aldosterone antagonist available, is poorly tolerated. The introduction of eplerenone, an aldosterone receptor antagonist with greater specificity for the mineralocorticoid receptor than spironolactone, may help improve this therapeutic approach.

        Norman K. Hollenberg, MD, PhD, with the Department of Medicine, at Brigham and Women's Hospital and Harvard Medical School, Boston, United States and colleagues compared eplerenone with amlodipine in 269 patients older than 50 years with systolic hypertension.

        Patients were randomised to receive eplerenone, 50 mg/d, or amlodipine, 2.5 mg/d, and this was titrated to a maximum dose of 200 mg eplerenone or 10 mg amlodipine.

        Patients were followed for 24 weeks. Quality-of-life was evaluated with the SF-36 Health Survey and the Symptom Distress Index (SDI) at randomisation and at the end of treatment.

        Eplerenone and amlodipine were found to reduce systolic blood pressure to a similar extent (eplerenone = -20.5 mm Hg and amlodipine = -20.1 mm Hg).

        For the quality-of-life analysis, 119 patients were randomised to eplerenone and 122 to amlodipine. There was an overall significant treatment effect on symptom distress in favour of eplerenone (p=0.03), and a significant worsening of symptom distress in 36 of 71 symptoms in the amlodipine arm compared to none in the eplerenone arm.

        "Significant treatment effect in favour of eplerenone was observed in 5 symptoms: ankle swelling, weight gain, nocturia, increased urination, and shortness of breath," the researchers note. "Patients with symptom distress also showed an erosion of psychosocial measures of quality of life (p<0.001)," they add.

        According to Dr. Hollenberg and colleagues, hyperkalemia occurred in 2 eplerenone-treated patients and in 1 amlodipine-treated patient, while hypokalemia occurred in 2 amlodipine-treated patients, and in no eplerenone-treated patients. Erectile dysfunction was reported in 2 of 61 eplerenone-treated men, and in no amlodipine-treated men. Oedema was present in 25.2% of the amlodipine-treated patients and 4.5% of the eplerenone-treated patients.

        "The availability of a new, specific, effective, and well-tolerated aldosterone receptor antagonists (sic) will facilitate the exploration of the clinical implications of these findings," the researchers conclude. "The results of this study suggest that eplerenone may be such an agent."
        Arch Intern Med 2003;163:1543-1548. "Symptoms and the Distress They Cause: Comparison of an Aldosterone Antagonist and a Calcium Channel Blocking Agent in Patients With Systolic Hypertension"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send